105 related articles for article (PubMed ID: 22338196)
1. Improved survival outcomes for melanoma of unknown primary in the era of novel therapies: A population-based retrospective analysis.
Tupper CJ; Clausen MC; Cogua LM; Silberstein PT
J Am Acad Dermatol; 2024 Jul; 91(1):111-113. PubMed ID: 38458569
[No Abstract] [Full Text] [Related]
2. Targeted therapy for melanoma: a primer.
Davies MA; Gershenwald JE
Surg Oncol Clin N Am; 2011 Jan; 20(1):165-80. PubMed ID: 21111965
[TBL] [Abstract][Full Text] [Related]
3. Innovative cancer therapies offer new hope.
Brody H
Nature; 2024 May; 629(8014):S1. PubMed ID: 38811701
[No Abstract] [Full Text] [Related]
4. Highlights of novel melanoma therapies presented at the 8th International Congress of the Society for Melanoma Research (SMR) Tampa, FL, November 9-11, 2011.
Herlyn D
Cancer Immunol Immunother; 2012 Jun; 61(6):949-51. PubMed ID: 22392191
[No Abstract] [Full Text] [Related]
5. Improving cancer stem cells killing in malignant melanoma.
Bergamaschi D
Br J Dermatol; 2024 Apr; 190(5):615-616. PubMed ID: 38282338
[No Abstract] [Full Text] [Related]
6. Resolution of an intracardiac metastasis with targeted therapy in a patient with melanoma.
Hampal R; Knott K; Nikolou E; Bunce N
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732359
[No Abstract] [Full Text] [Related]
7. [Ⅲ. Treatments for Skin Cancers Based on the Genetic Information].
Inozume T
Gan To Kagaku Ryoho; 2024 Apr; 51(4):404-408. PubMed ID: 38644306
[No Abstract] [Full Text] [Related]
8. [New treatments for metastatic melanoma: a first hope].
Robert C; Mateus C
Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
[No Abstract] [Full Text] [Related]
9. Melanoma: from darkness to promise.
Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
[TBL] [Abstract][Full Text] [Related]
10. The conquest of melanoma by immunotherapy.
Lejeune FJ
Melanoma Res; 2015 Oct; 25(5):373-5. PubMed ID: 26173006
[No Abstract] [Full Text] [Related]
11. Advances in the treatment of late stage melanoma.
Walkington LA; Lorigan P; Danson SJ
BMJ; 2013 Mar; 346():f1265. PubMed ID: 23460638
[No Abstract] [Full Text] [Related]
12. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy of melanoma].
Dréno B
Bull Acad Natl Med; 2010 Oct; 194(7):1373-81. PubMed ID: 22043632
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
